GoodRx Care Review

GoodRx Care — Provider Profile

Overview

GoodRx Care is the telehealth arm of GoodRx Holdings (NASDAQ: GDRX), the company best known for its prescription discount cards. Originally launched in 2019 after GoodRx acquired the telehealth startup HeyDoctor, the platform has expanded into GLP-1 weight loss prescribing as GoodRx's core discount card business has faced mounting competition from Amazon Pharmacy and Mark Cuban's Cost Plus Drugs.

GoodRx Care positions itself as a brand-medication-only platform — it does not offer compounded semaglutide or tirzepatide. This was a deliberate differentiator, and it has paid off: as the compounded GLP-1 market faces escalating FDA enforcement pressure and supply decline in 2026, GoodRx never had to navigate the compounding disruptions that hit competitors like Hims and Henry Meds. The brand-only bet is looking prescient.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending. Compounded semaglutide supply is declining under FDA enforcement pressure.

Pricing and protocol data sourced from this provider's public website, verified April 2026. Patient experience data from verified patient reports. We have no commercial relationship with this provider.

Medications Offered

• Orforglipron (oral pill) — Awaiting FDA approval (PDUFA April 10, 2026); announced at $149/mo through LillyDirect; expected to be added upon approval
• Brand oral Wegovy (semaglutide pill) — Daily oral tablet at cash-pay pricing
• Brand Wegovy (semaglutide injection) — Weekly subcutaneous injection, available via insurance
• Brand Wegovy HD (semaglutide 7.2mg) — Higher-dose injectable (not yet FDA-approved as of April 2026)
• Brand Zepbound (tirzepatide injection) — Weekly subcutaneous injection, available via insurance or LillyDirect $299/mo
• CagriSema — Expected post-FDA approval (NDA filed Dec 2025, decision pending 17+ months)

GoodRx Care does not offer compounded GLP-1 medications. With the compounded market collapsed to <1% of 2024 peak supply, this is now the industry standard.

Pricing

Pricing last verified April 2026. Confirm current pricing directly with the provider before enrolling.

True monthly cost: Once orforglipron is approved (PDUFA April 10, 2026), the expected total cost through GoodRx Care would be $188/month ($39 subscription + $149 medication). Oral Wegovy at 4mg is $238/month ($39 + $199) today. For injectables, the introductory $199/month for first two fills is competitive, but the standard $349/month is steep. Medicare-eligible patients are expected to pay approximately $50/month through the Bridge program (scheduled July 2026).

GoodRx's pharmacy discount infrastructure remains a unique advantage. For brand injectables covered by insurance, GoodRx can help find the lowest pharmacy copay — a perk no other telehealth provider offers.

States Served

Available in 48+ US states. The service is entirely virtual — no in-person visits required.

Insurance

• Insurance is not required for the oral Wegovy program ($199/mo cash-pay + $39/mo subscription)
• Brand injectable medications (Wegovy, Zepbound) require insurance coverage
• HSA/FSA cards accepted
• GoodRx discount card integration can help patients find the lowest pharmacy price for brand medications — a unique perk from the parent company's core business

Consultation Process

Model: Async consultations — no video visits.

1. Complete an online health questionnaire covering medical history, current medications, BMI, and weight loss goals
2. A licensed provider reviews your submission (not necessarily an obesity medicine specialist)
3. If clinically appropriate, a prescription is issued
4. Medication ships to the patient or is sent to a local pharmacy for pickup
5. Ongoing provider access is included in the monthly program fee

The async-only model keeps costs low and removes scheduling friction, but it also means patients don't get face-to-face time with a clinician. There is no dietitian access, no structured coaching, and no lab work included — this is a prescription service, not a comprehensive weight management program.

Pros

• Orforglipron at $149/mo ($188/mo total with subscription) — most affordable branded oral GLP-1 path
• Oral Wegovy access at $199/month (+ $39 subscription) — below retail pricing
• Brand-medication-only approach means zero compounding disruption risk
• $39/month subscription keeps ongoing provider access affordable
• GoodRx discount card integration for finding the best pharmacy pricing
• Established parent company with broad brand recognition and trust
• Medicare Bridge program support ($50/mo for eligible patients)

Cons

• Limited clinical depth: providers are licensed but not necessarily obesity medicine specialists
• No dietitian access, nutrition coaching, or behavioral support included
• No lab work included or coordinated
• Async-only consultations — no video or phone visits with providers
• $39/mo subscription adds up vs. providers with no separate platform fee
• Injectable pricing ($349/mo standard) is above competitors like LillyDirect ($299/mo for Zepbound)

Best For

Patients who want affordable branded oral GLP-1 access — either oral Wegovy ($199/mo, available now) or orforglipron ($149/mo, expected upon FDA approval on April 10, 2026) — from a trusted platform with pharmacy discount integration. GoodRx Care is a good fit for patients who want a straightforward prescription service without needing specialist consultations, dietitian access, or comprehensive coaching. Also strong for Medicare-eligible patients expecting to use the Bridge program (scheduled July 2026).

Editorial Verdict

GoodRx Care's brand-only bet has aged well. While competitors have scrambled through the compounding shutdown of early 2026, GoodRx was unaffected. The anticipated addition of orforglipron at $149/month through LillyDirect — pending FDA approval on April 10, 2026 — would make the platform even more competitive on price, with a total cost of $188/month (subscription + medication) in striking distance of direct-to-consumer options.

The oral Wegovy pricing ($199/mo + $39 subscription = $238/month) remains solid but is no longer the cheapest branded oral path. Orforglipron through the same platform is $50/month less and has no food timing restrictions. For injectable patients, the $349/month standard price is still above LillyDirect's $299/month for Zepbound direct, though GoodRx's pharmacy discount integration can sometimes find better prices through insurance.

The clinical model remains thin — async questionnaires reviewed by general practitioners, with no obesity medicine specialists, dietitians, or lab coordination. For patients who need more hands-on clinical guidance, platforms like Mochi Health, FORM Health, or Calibrate offer meaningfully more support.

Bottom line as of April 2026: GoodRx Care is a solid choice for patients who want simple, affordable branded oral GLP-1 access and value the pharmacy discount ecosystem. Oral Wegovy at $238/month total is available now; orforglipron at $188/month total is expected upon FDA approval (PDUFA April 10, 2026). Wegovy HD gives injectable patients a higher-efficacy path. CagriSema expected to be added post-FDA decision.

Data Sources

Pricing and protocol information sourced from GoodRx Care's official website (verified April 2026). Consultation process details sourced from provider onboarding flow documentation. Patient experience descriptions sourced from public patient reviews. Telehealth Ally has no affiliate or commercial relationship with this provider.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• Cheapest GLP-1 Providers — Budget options compared
• Oral vs Injectable GLP-1 Medications — How the new pill formulations compare
• GLP-1 Cost & Insurance FAQ — What you'll actually pay

GoodRx Weight Loss Review 2026: Pricing, How It Works, and Who It's Best For

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

GoodRx Holdings (NASDAQ: GDRX) has completely overhauled its weight loss program in 2026. The telehealth subscription dropped from $119/month to $39/month — a 67% price cut that makes it the cheapest telehealth access fee in the GLP-1 market. They've also introduced a $199/month introductory price for brand Ozempic and Wegovy, and the program remains brand-name only — no compounded medications.

The new pricing model is a major pivot. GoodRx is betting that a low-cost telehealth subscription plus introductory brand medication pricing can capture patients who have been priced out of the $200+/month all-in telehealth market. Here's our full review of the overhauled program.

Editorial Independence Note: Telehealth Ally does not accept sponsorship or payment from any provider reviewed on this site. Our reviews are based on publicly available pricing, clinical evidence, and editorial research. Revenue never influences our ratings or recommendations.

How does GoodRx Care's weight loss program work?

GoodRx Care is a prescription service, not a holistic weight management program. The $39/month subscription covers provider access and prescription writing — medication costs are separate.

1. Sign up for the telehealth subscription ($39/mo) — This covers ongoing provider access, messaging, dose adjustments, and prescription management. Down from $119/mo — one of the cheapest telehealth fees in the market.
2. Online intake — Complete a health questionnaire covering medical history, current medications, BMI, and weight loss goals.
3. Async provider review — A licensed provider reviews your submission. GoodRx uses an async-only model — no video or phone consultations.
4. Prescription issued — If clinically appropriate, a prescription for oral Wegovy, Ozempic, or another brand GLP-1 is sent to a pharmacy.
5. Medication delivery — Brand medications ship directly or can be picked up at a local pharmacy. GoodRx's intro pricing applies through their pharmacy network.
6. Ongoing access — Provider messaging for dose adjustments and questions is included in the $39/mo subscription.

GoodRx Care does not include dietitian access, structured coaching, behavioral support, or lab work. This is a prescription service, not a holistic weight management program.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

How much does GoodRx weight loss cost per month?

GoodRx's total cost depends on which medication you use. The $39/month subscription is the cheapest access fee in the market, and the $199/month introductory brand medication pricing makes the combined cost competitive at $238/month — though intro pricing applies only to the first two fills at lower doses.

What changed: The old model bundled a $119/month subscription with medication costs on top. The new model slashes the subscription to $39/month and introduces a $199/month introductory price for brand Ozempic and Wegovy. Total cost for the intro program: $238/month ($39 sub + $199 medication), which is competitive with all-in telehealth pricing from Hims and Ro.

HSA and FSA cards are accepted. For a full pricing comparison, see our GLP-1 pricing breakdown by provider.

What medications does GoodRx Care offer?

GoodRx Care is brand-name only — no compounded medications. With the FDA issuing 30+ warning letters to compounding firms in 2026, GoodRx's brand-only stance has become an advantage for patients who want to avoid compounding risk.

• Brand oral Wegovy (semaglutide pill) — A daily oral tablet and GoodRx Care's primary weight loss offering. This is one of the newer GLP-1 formulations, offering a needle-free alternative to weekly injections. Available at a cash-pay price.
• Brand Wegovy (semaglutide injection) — The FDA-approved weekly subcutaneous injection for chronic weight management. Available via insurance only.
• Brand Zepbound (tirzepatide injection) — A dual GIP/GLP-1 receptor agonist approved for chronic weight management. Available via insurance only.

What GoodRx Care does NOT offer: Compounded semaglutide, compounded tirzepatide, or non-GLP-1 weight loss medications. This remains a deliberate choice — and with the FDA's 30+ warning letters to compounding firms in 2026, GoodRx's brand-only stance looks increasingly prescient. Note that Hims has also exited compounding entirely, becoming an authorized brand distributor after the March 9 Novo settlement.

How effective are GoodRx Care's medications?

The clinical evidence for the active ingredients in GoodRx Care's offerings is well-established:

• Semaglutide (STEP 1): Participants receiving 2.4mg weekly semaglutide lost a mean of 14.9% body weight over 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM 2021).
• Oral semaglutide (OASIS 1): The oral formulation of semaglutide 50mg daily demonstrated approximately 15.1% body weight reduction over 68 weeks vs 2.4% with placebo (Knop et al., The Lancet 2023). These results suggest oral semaglutide can achieve weight loss comparable to the injectable formulation.
• Tirzepatide (SURMOUNT-1): Participants on the highest dose (15mg) lost a mean of 22.5% body weight over 72 weeks vs 2.4% with placebo (Jastreboff et al., NEJM 2022).

Because GoodRx Care prescribes brand-name FDA-approved medications exclusively, patients receive the same formulations studied in these clinical trials. That said, individual results vary based on adherence, lifestyle factors, dose titration, and metabolic differences. Research into long-term outcomes beyond 72 weeks is ongoing.

What are the pros of GoodRx Care?

• $39/month telehealth subscription — The cheapest telehealth access fee in the GLP-1 market. Down from $119/month — a 67% price cut that makes GoodRx the lowest-barrier entry point for brand GLP-1 access.
• $199/month intro brand medication pricing — Introductory pricing for Ozempic and Wegovy through GoodRx's pharmacy network.
• Brand-medication only — Eliminates compounding safety concerns entirely. Every medication prescribed is an FDA-approved finished drug product. This matters more now that the FDA has issued 30+ warning letters to compounding firms.
• GoodRx discount card integration — Patients filling brand injectables through insurance can use GoodRx's core pricing tools to find the lowest copay at local pharmacies. No other GLP-1 telehealth provider has this built-in advantage.
• Publicly traded company — NASDAQ-listed with audited financials and SEC oversight.
• Transparent pricing — Subscription and medication costs clearly separated. No hidden fees.
• HSA/FSA accepted — Helps offset out-of-pocket costs.

What are the cons of GoodRx Care?

• No compounded GLP-1 options — Patients without insurance who can't afford $199+/month for brand medications have no affordable alternatives on this platform.
• Async-only care — No video or phone consultations. Some patients prefer face-to-face interaction, especially when titrating doses or managing side effects.
• No lab work — Metabolic blood work is not included, ordered, or coordinated. Patients must arrange labs independently.
• No dietitian or coaching support — No behavioral support, nutrition guidance, or structured lifestyle programming.
• Providers are not obesity specialists — Consultations are handled by general licensed providers, not board-certified obesity medicine physicians.
• Intro medication pricing may expire — The $199/month brand intro pricing has not been committed as permanent. Track whether this holds.
• Limited medication options — Only GLP-1 medications; no broader weight management pharmacotherapy.

Who is GoodRx Care best for?

• Budget-conscious patients wanting brand medications — The $39/month subscription is the cheapest telehealth entry point. Combined with $199/month intro medication pricing, GoodRx offers a genuinely low-cost path to brand GLP-1s. If you're asking how to get GLP-1 without insurance and prefer FDA-approved medications, GoodRx Care is one of the best-value options available.
• People who specifically want brand-name FDA-approved medications — With compounding under heavy FDA scrutiny, GoodRx's brand-only approach provides peace of mind and regulatory safety.
• Existing GoodRx users — If you already rely on GoodRx discount cards for pharmacy savings, the integrated experience adds value.
• Patients with insurance coverage for brand injectables — GoodRx's discount card tools can help you find the best copay pricing at local pharmacies.
• Patients anticipating orforglipron — Once approved (PDUFA April 10, 2026), at $39/month for telehealth access plus $149/month for orforglipron, the total cost would be competitive with any provider.

Who should look elsewhere?

• Patients who need the absolute cheapest GLP-1 access — Compounded semaglutide ($129–$199/month) from remaining compounding providers is still cheaper than brand medications, though with higher regulatory risk. Orforglipron at $149/month via LillyDirect is also worth comparing.
• People wanting comprehensive weight management — Calibrate and Found offer structured coaching, dietitian access, and behavioral support alongside medication.
• Patients who want video consultations or specialist care — Mochi Health and Calibrate provide more clinical depth and face-to-face provider interaction.
• Those needing lab work coordination — GoodRx does not include or arrange metabolic labs.
• Patients looking for tirzepatide without insurance — GoodRx has no cash-pay tirzepatide option. LillyDirect offers Zepbound at $299/month.

Frequently Asked Questions

Does GoodRx Care prescribe compounded semaglutide? No. GoodRx Care only prescribes brand-name FDA-approved medications. This means no compounded semaglutide or compounded tirzepatide. If you want compounded options, see our cheapest GLP-1 providers guide.

How much does GoodRx weight loss cost per month? The telehealth subscription is $39/month (down from $119/month). Brand Ozempic/Wegovy is available at a $199/month introductory price through GoodRx's pharmacy network. Total cost for the intro program: $238/month. Brand injectable Wegovy and Zepbound are also available through insurance.

Is oral Wegovy as effective as injectable Wegovy? Clinical trials suggest oral semaglutide achieves comparable weight loss to the injectable formulation (approximately 15% body weight reduction over 68 weeks). However, the oral and injectable forms use different dosing regimens, and individual responses may vary. Research comparing the two formulations directly is ongoing.

Does GoodRx Care accept insurance? Insurance is not required for the $149/month oral Wegovy program (cash-pay). Brand injectable medications (Wegovy, Zepbound) require insurance coverage. HSA and FSA cards are accepted for all services.

What states is GoodRx Care available in? GoodRx Care is available in 48+ US states. The service is entirely virtual with no in-person visits required.

Can I use my GoodRx discount card with GoodRx Care prescriptions? Yes. GoodRx's discount card tools are integrated into the platform, which can help patients find the lowest pharmacy pricing for brand medications — particularly useful for brand injectables filled through insurance.

Is GoodRx Care worth it? GoodRx Care is worth it if you want brand medications at the lowest available access fee and are comfortable with async-only care. At $238/month total during the intro period, it's among the most competitive brand GLP-1 options. It's not worth it if you need coaching, lab work, or specialist-level care.

Is GoodRx Care worth it?

GoodRx Care's 2026 overhaul transformed it from an overpriced brand-only telehealth service into one of the most cost-effective entry points for GLP-1 treatment. The $39/month telehealth subscription is the cheapest in the market, and the $199/month brand medication intro pricing makes the total cost ($238/month) competitive with providers that bundle everything together.

The limitations are real but unchanged. No compounded alternatives, async-only care, no specialists, no labs, no coaching. GoodRx Care is still a prescription service, not a weight management program. But at this price point, it's a strong option for patients who want brand medication access without paying premium subscription fees.

The biggest question is whether the $199/month intro medication pricing will hold. If it does, GoodRx becomes one of the best value propositions in the GLP-1 telehealth market. If it expires, the platform reverts to standard brand pricing, which is less compelling.

Rating: 4.0/5 (up from 3.7 — pricing overhaul significantly improves value proposition)

Data Sources & Methodology

Pricing and protocol data sourced from GoodRx's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.

Related Resources

• GoodRx Care Provider Profile — Full provider details, medications, and pricing
• Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
• GLP-1 Pricing Breakdown by Provider — Compare costs across platforms
• Oral vs Injectable GLP-1 Medications — How the new pill formulations compare
• Cheapest GLP-1 Providers — Budget options compared
• GLP-1 Cost & Insurance FAQ — What you'll actually pay